Apeloa Pharmaceutical Co., Ltd. (000739) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Apeloa Pharmaceutical Co., Ltd.

Why is Apeloa Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 6.65% and Operating profit at 1.13% over the last 5 years

With a fall in EPS of -10.88%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 2 consecutive quarters
OPERATING CASH FLOW(Y) Lowest at CNY 847.13 MM
ROCE(HY) Lowest at 13.19%
NET SALES(Q) Lowest at CNY 2,319.4 MM

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Apeloa Pharmaceutical Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Apeloa Pharmaceutical Co., Ltd.

11.06%

0.42

29.28%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.65%

EBIT Growth (5y)

1.13%

EBIT to Interest (avg)

41.94

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.11

Sales to Capital Employed (avg)

1.19

Tax Ratio

13.86%

Dividend Payout Ratio

40.00%

Pledged Shares

Institutional Holding

ROCE (avg)

18.98%

ROE (avg)

17.14%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.83

EV to EBIT

20.72

EV to EBITDA

12.23

EV to Capital Employed

2.94

EV to Sales

1.70

PEG Ratio

Dividend Yield

4.35%

ROCE (Latest)

14.18%

ROE (Latest)

14.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -7.29% (YoY

-28What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 847.13 MM

ROCE(HY)

Lowest at 13.19%

NET SALES(Q)

Lowest at CNY 2,319.4 MM

INTEREST(Q)

At CNY 6.24 MM has Grown at 10.08%

INTEREST COVERAGE RATIO(Q)

Lowest at 2,484.34

OPERATING PROFIT(Q)

Lowest at CNY 155.09 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.69 %

PRE-TAX PROFIT(Q)

At CNY 181.41 MM has Fallen at -34.56%

NET PROFIT(Q)

Lowest at CNY 137.18 MM

EPS(Q)

Lowest at CNY 0.12

Here's what is working for Apeloa Pharmaceutical Co., Ltd.

Raw Material Cost

Fallen by -7.29% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Apeloa Pharmaceutical Co., Ltd.

Net Sales

At CNY 2,319.4 MM has Fallen at -15.86%

over average net sales of the previous four periods of CNY 2,756.52 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Net Sales

Lowest at CNY 2,319.4 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest

At CNY 6.24 MM has Grown at 10.08%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 2,484.34

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Profit

At CNY 137.18 MM has Fallen at -42.86%

over average net sales of the previous four periods of CNY 240.06 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 847.13 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 155.09 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 6.69 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

At CNY 181.41 MM has Fallen at -34.56%

over average net sales of the previous four periods of CNY 277.24 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 137.18 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.12

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)